nach oben

Erschienen in:

25.07.2023 | Position Statement

Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects

verfasst von: Matteo Monami, Alessia Scatena, Cesare Miranda, Luca Monge, Alessandro De Cassai, Antonio Volpe, Rodolfo Tramonta, Gerardo Medea, Corrado Bordieri, Marco Falcone, Laura Stefanon, Andrea Bernetti, Cristina Cappella, Mauro Gargiulo, Valentina Lorenzoni, Germano Scevola, Eugenio Stabile, Benedetta Ragghianti, Giovanni Antonio Silverii, Roberto da Ros, Marco Meloni, Laura Giurato, Giuseppe Murdolo, Eleonora Bianchini, Francesco Gaggia, Carlotta Gauna, Francesco Romeo, Matteo Apicella, Michele Mantuano, Luigi Uccioli, Cristiana Vermigli, for the Panel of the Italian Guidelines for the treatment of Diabetic Foot Syndrome and on behalf of SID and AMD

Erschienen in: Acta Diabetologica | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Aims

Diabetic foot syndrome (DFS) and its complications are a growing public health concern. The Italian Society of Diabetology (SID) and the Italian Association of Clinical Diabetologists (AMD), in collaboration with other scientific societies, will develop the first Italian guidelines for the treatment of DFS.

Methods

The creation of SID/AMD Guidelines is based on an extended work made by 19 panelists and 12 members of the Evidence Review Team. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) methodology has been used to decide aims, reference population, and target health professionals. Clinical questions have been created using PICO (Patient, Intervention, Comparison, Outcome) conceptual framework. The definition of questions has been performed using a two-step web-based Delphi methodology, a structured technique aimed at obtaining by repeated rounds of questionnaires a consensus opinion from a panel of experts in areas wherein evidence is scarce or conflicting, and opinion is important.

Results

The mean age of panelists (26.3% women) was 53.7 ± 10.6 years. The panel proposed 34 questions. A consensus was immediately reached for all the proposed questions, 32 were approved and 2 were rejected.

Conclusions

The areas covered by clinical questions included diagnosis of ischemia and infection, treatment of ischemic, neuropathic, and infected ulcers, prevention of foot ulceration, organization and education issues, and surgical management. The PICO presented in this paper are designed to provide indications for healthcare professionals in charge of diabetic foot treatment and prevention, primarily based on clinical needs of people with diabetic foot syndrome and considering the existing organization of health care.

Nur mit Berechtigung zugänglich

Monami M, Ragghianti B, Nreu B, et al (2022) Major amputation in non-healing ulcers: outcomes and economic issues. data from a cohort of patients with diabetic foot ulcers. Int J Low Extrem Wounds. https://doi.org/10.1177/15347346221097283CrossRefPubMed

Matricali GA, Dereymaeker G, Muls E, Flour M, Mathieu C (2007) Economic aspects of diabetic foot care in a multidisciplinary setting: a review. Diabetes Metab Res Rev 23(5):339–347. https://doi.org/10.1002/dmrr.706CrossRefPubMed

Meza-Torres B, Carinci F, Heiss C, Joy M, de Lusignan S (2021) Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: systematic review and meta-analysis. Acta Diabetol 58(6):735–747. https://doi.org/10.1007/s00592-020-01662-xCrossRefPubMedPubMedCentral

Musuuza J, Sutherland BL, Kurter S, Balasubramanian P, Bartels CM, Brennan MB (2020) A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg 71(4):1433-1446.e3. https://doi.org/10.1016/j.jvs.2019.08.244CrossRefPubMed

Hinchliffe RJ, Forsythe RO, Apelqvist J, et al (2020) Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.3276CrossRefPubMed

Lazzarini PA, Raspovic A, Prentice J, et al (2022) Guidelines development protocol and findings: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease. J Foot Ankle Res. https://doi.org/10.1186/s13047-022-00533-8CrossRefPubMedPubMedCentral

http://www.quotidianosanita.it/allegati/allegato503046.pdf.

Guyatt GH, Oxman AD, Santesso N et al (2013) GRADE guidelines: 12. preparing summary of findings tables—binary outcomes. J Clin Epidemiol 66(2):158–172. https://doi.org/10.1016/j.jclinepi.2012.01.012CrossRefPubMed

https://snlg.iss.it/wp-content/uploads/2019/04/MM_v1.3.2_apr_2019.pdf.

10.

de Villiers MR, de Villiers PJT, Kent AP (2005) The delphi technique in health sciences education research. Med Teach 27(7):639–643. https://doi.org/10.1080/13611260500069947CrossRefPubMed

11.

Giannarou L, Zervas E (2014) Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manage (IJBSAM) 9(2):65–82

12.

Walker A, Selfe J (1996) The Delphi method: a useful tool for the allied health researcher. Br J Ther Rehabil 3(12):677–681CrossRef

13.

De Luca M, Zappa MA, Zese M et al (2022) Development of the Italian clinical practice guidelines on bariatric and metabolic surgery: design and methodological aspects. Nutrients 15(1):189. https://doi.org/10.3390/nu15010189CrossRefPubMedPubMedCentral

14.

Russo G, Monami M, Perseghin G, et al (2021) The “early treatment” approach reducing cardiovascular risk in patients with type 2 diabetes: a consensus from an expert panel using the delphi technique. Diabetes Ther 12(5):1445–1461. https://doi.org/10.1007/s13300-021-01045-7CrossRefPubMedPubMedCentral

15.

Blanchette V, Brousseau-Foley M, Cloutier L (2020) Effect of contact with podiatry in a team approach context on diabetic foot ulcer and lower extremity amputation: systematic review and meta-analysis. J Foot Ankle Res. https://doi.org/10.1186/s13047-020-0380-8CrossRefPubMedPubMedCentral

16.

Alexandrescu V, Hubermont G, Coessens V et al (2009) Why a multidisciplinary team may represent a key factor for lowering the inferior limb loss rate in diabetic neuro-ischaemic wounds: application in a departmental institution. Acta Chir Belg 109(6):694–700. https://doi.org/10.1080/00015458.2009.11680519CrossRefPubMed

17.

Ayada G, Edel Y, Burg A, et al (2021) Multidisciplinary team led by internists improves diabetic foot ulceration outcomes a before-after retrospective study. Eur J Intern Med 94:64–68. https://doi.org/10.1016/j.ejim.2021.07.007CrossRefPubMed

18.

Blanchette V, Hains S, Cloutier L (2019) Establishing a multidisciplinary partnership integrating podiatric care into the Quebec public health-care system to improve diabetic foot outcomes: a retrospective cohort. Foot 38:54–60. https://doi.org/10.1016/j.foot.2018.10.001CrossRefPubMed

19.

Hsu CR, Chang C-C, Chen Y-T, Lin W-N, Chen M-Y (2015) Organization of wound healing services: the impact on lowering the diabetes foot amputation rate in a ten-year review and the importance of early debridement. Diabetes Res Clin Pract 109(1):77–84. https://doi.org/10.1016/j.diabres.2015.04.026CrossRefPubMed

20.

Riaz M, Miyan Z, Waris N, et al (2019) Impact of multidisciplinary foot care team on outcome of diabetic foot ulcer in term of lower extremity amputation at a tertiary care unit in Karachi, Pakistan. Int Wound J 16(3):768–772. https://doi.org/10.1111/iwj.13095CrossRefPubMedPubMedCentral

21.

Yesil S, Akinci B, Bayraktar F et al (2009) Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey. Exp Clin Endocrinol Diabetes 117(7):345–349. https://doi.org/10.1055/s-0028-1112149CrossRefPubMed

22.

Brouwers MC, Kho ME, Browman GP, et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 63(12):1308–1311. https://doi.org/10.1016/j.jclinepi.2010.07.001CrossRefPubMed

Titel: Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects
verfasst von: Matteo Monami
Alessia Scatena
Cesare Miranda
Luca Monge
Alessandro De Cassai
Antonio Volpe
Rodolfo Tramonta
Gerardo Medea
Corrado Bordieri
Marco Falcone
Laura Stefanon
Andrea Bernetti
Cristina Cappella
Mauro Gargiulo
Valentina Lorenzoni
Germano Scevola
Eugenio Stabile
Benedetta Ragghianti
Giovanni Antonio Silverii
Roberto da Ros
Marco Meloni
Laura Giurato
Giuseppe Murdolo
Eleonora Bianchini
Francesco Gaggia
Carlotta Gauna
Francesco Romeo
Matteo Apicella
Michele Mantuano
Luigi Uccioli
Cristiana Vermigli
for the Panel of the Italian Guidelines for the treatment of Diabetic Foot Syndrome and on behalf of SID and AMD
Publikationsdatum: 25.07.2023
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 11/2023
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-023-02150-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2023

Coexisiting type 1 diabetes and celiac disease is associated with lower Hba1c when compared to type 1 diabetes alone: data from the Australasian Diabetes Data Network (ADDN) registry

Pregestational exposure to hormonal combined contraceptives and risk of gestational diabetes: an observational retrospective population study

On the occasion of the centennial of the Nobel Prize in Physiology or Medicine, 1923: Nicolae C. Paulescu—between scientific creativity and political fanatism

Effect of obesity on fragility fractures, BMD and vitamin D levels in postmenopausal women. Influence of type 2 diabetes mellitus

METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1

Does nutritional guidance reduce cardiovascular events in patients with type 2 diabetes mellitus? A retrospective cohort study using a nationwide claims database